- Research
- Open Access
The use of a Cissus quadrangularis/Irvingia gabonensis combination in the management of weight loss: a double-blind placebo-controlled study
Lipids in Health and Disease20087:12
https://doi.org/10.1186/1476-511X-7-12
© Oben et al; licensee BioMed Central Ltd. 2008
Received: 17 February 2008
Accepted: 31 March 2008
Published: 31 March 2008
Authors’ Affiliations
(1)
Laboratory of Nutrition and Nutritional Biochemistry, Department of Biochemistry, B.P. 812, University of Yaoundé 1, Yaoundé, Cameroon
(2)
CRPMT, Institute of Medicinal Plants Studies, Yaoundé, Cameroon
Archived Comments
Cissus quadrangularis, fat loss and competing interests
7 May 2008
Anssi Manninen, Manninen Nutraceuticals Oy
The lead author of this study has a patent on Cissus quadrangularis as a fat loss agent. A competing interest exists when professional judgement concerning a primary interest may be influenced by a secondary interest (e.g., financial gain). While there is nothing inherently unethical about a competing interest, they should be acknowledged and openly stated.
Anssi Manninen
Manninen Nutraceuticals Oy
Oulu, Finland
Competing interests
None.